| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2020-10-30 |
复牌提示：
2020-10-29 19:50:10 停牌，复牌日期 2020-11-02 00:00:01
|
| 2020-10-30 |
详情>>
内部人交易：
Fenwick Sandra L等共交易10笔
|
| 2020-10-28 |
财报披露：
美东时间 2020-10-28 盘后发布财报
|
| 2020-09-15 |
股东大会：
将于2020-10-29召开股东大会
会议内容 ▼▲
- 1.to adopt the Agreement and Plan of Merger, dated as of August 5, 2020 (as it may be amended from time to time), which is referred to as the merger agreement, by and among Teladoc Health, Inc., referred to as Teladoc, Livongo and Tempranillo Merger Sub, Inc., a wholly-owned subsidiary of Teladoc, which proposal is referred to as the Livongo merger agreement proposal;
2.to approve, on an advisory (non-binding) basis, the executive officer compensation that will or may be paid to Livongo’s named executive officers that is based on or otherwise relates to the transactions contemplated by the merger agreement, which is referred to as the Livongo compensation proposal;
3.to approve the adjournment of the Livongo stockholder meeting to solicit additional proxies if there are not sufficient votes at the time of the Livongo stockholder meeting to approve the Livongo merger agreement proposal or to ensure that any supplement or amendment to the accompanying joint proxy statement/prospectus is timely provided to Livongo stockholders, which is referred to as the Livongo adjournment proposal.
|
| 2020-09-15 |
详情>>
股本变动：
变动后总股本10158.54万股
|
| 2020-08-10 |
详情>>
业绩披露：
2020年中报每股收益-0.07美元,归母净利润-712.7万美元,同比去年增长75.66%
|
| 2020-05-07 |
详情>>
业绩披露：
2020年一季报每股收益-0.06美元,归母净利润-557.3万美元,同比去年增长62.85%
|
| 2020-04-06 |
股东大会：
将于2020-05-19召开股东大会
会议内容 ▼▲
- 1.To elect two Class I directors to hold office until the 2023 annual meeting of stockholders or until their successors are elected and qualified, subject to their earlier death, resignation or removal.
2.To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2020.
3.To transact such other business that may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2020-03-24 |
详情>>
业绩披露：
2019年年报每股收益-1.09美元,归母净利润-5536.6万美元,同比去年增长-65.05%
|
| 2019-11-08 |
详情>>
业绩披露：
2019年三季报(累计)每股收益-1.34美元,归母净利润-4901.2万美元,同比去年增长-132.94%
|
| 2019-09-05 |
详情>>
业绩披露：
2019年中报每股收益-1.58美元,归母净利润-2928.7万美元,同比去年增长-179.38%
|
| 2019-07-25 |
详情>>
业绩披露：
2018年年报每股收益-2.02美元,归母净利润-3354.4万美元,同比去年增长-97.31%
|
| 2019-07-25 |
详情>>
业绩披露：
2019年一季报每股收益-0.82美元,归母净利润-1500.1万美元,同比去年增长-252.8%
|